Stay updated on TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.

Latest updates to the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page
- Check6 days agoChange DetectedThe page now displays Revision: v3.5.3, replacing Revision: v3.5.2. This updates the page's revision history to reflect the latest release.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a new publication entry for KEYNOTE-522 Japan Subgroup Analysis (Cancer Sci. 2026 Apr;117(4):1106-1116; doi:10.1111/cas.70307). The prior entry listing 'Online ahead of print' was replaced with the April 2026 citation.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedLocation label updated from Napoli, Italy 80131 to Naples, Italy 80131 and version updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check56 days agoChange DetectedThe study record metadata now shows revision v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a publication reference by Kuemmel et al. about KEYNOTE-522 in Ann Surg Oncol to the Publications section.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding status notice and the earlier Revision: v3.4.1.SummaryDifference0.1%

Stay in the know with updates to TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.